Han-Chieh Lin Selected Research

Cannabinoids

11/2014	Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites.
7/2012	Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
5/2012	Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
6/2011	The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
10/2007	Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
2/2006	Roles of anandamide in the hepatic microcirculation in cirrhotic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han-Chieh Lin Research Topics

Disease

108	Fibrosis (Cirrhosis) 04/2024 - 01/2002
54	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 12/2004
50	Neoplasms (Cancer) 04/2024 - 12/2004
41	Portal Hypertension 01/2021 - 01/2002
34	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 11/2003
34	Hemorrhage 07/2020 - 02/2002
30	Inflammation (Inflammations) 01/2024 - 09/2009
29	End Stage Liver Disease 01/2024 - 12/2004
19	Infections 06/2023 - 01/2002
18	Liver Neoplasms (Liver Cancer) 04/2024 - 05/2006
15	Liver Diseases (Liver Disease) 01/2024 - 10/2003
14	Chronic Hepatitis C 04/2024 - 01/2020
14	Chronic Hepatitis B 09/2021 - 06/2010
14	Ascites 02/2020 - 01/2002
14	Hepatic Encephalopathy 01/2020 - 03/2005
12	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2016 - 05/2007
10	Hepatitis B 11/2023 - 01/2008
10	Necrosis 11/2023 - 05/2009
10	Fatty Liver 10/2022 - 06/2010
9	Body Weight (Weight, Body) 01/2019 - 05/2007
9	Ulcer 09/2016 - 05/2008
8	Peptic Ulcer (Peptic Ulcers) 09/2016 - 08/2009
7	Non-alcoholic Fatty Liver Disease 04/2024 - 05/2012
7	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 05/2007
7	Esophageal and Gastric Varices (Esophageal Varices) 01/2018 - 08/2005
6	Diabetes Mellitus 04/2024 - 05/2010
6	Bacterial Infections (Bacterial Infection) 01/2024 - 08/2002
6	Chronic Renal Insufficiency 01/2022 - 12/2011
6	Endotoxemia 11/2021 - 03/2009
6	Hepatitis 01/2020 - 05/2009
6	Stomach Ulcer (Gastric Ulcer) 09/2016 - 05/2008
5	Hepatitis C 01/2024 - 03/2016
5	Obesity 10/2023 - 10/2011
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2023 - 05/2010
5	Insulin Resistance 01/2023 - 01/2016
5	Hypertension (High Blood Pressure) 01/2020 - 06/2006
5	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2009
5	Hepatopulmonary Syndrome 11/2017 - 11/2005
5	Acute Liver Failure (Fulminant Hepatic Failure) 02/2012 - 03/2005
4	Cholecystitis 02/2020 - 10/2012
4	Sepsis (Septicemia) 01/2020 - 01/2008
4	Liver Failure 01/2020 - 07/2008
4	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2020 - 02/2010

Drug/Important Bio-Agent (IBA)

25	Antiviral Agents (Antivirals)IBA 04/2024 - 03/2010
22	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 01/2002
19	BilirubinIBA 01/2024 - 07/2008
17	AlbuminsIBA 01/2024 - 11/2005
16	Alanine Transaminase (SGPT)IBA 01/2021 - 07/2008
15	Cytidine Triphosphate (CTP)IBA 04/2017 - 12/2004
14	SodiumIBA 11/2017 - 01/2002
13	Vasoconstrictor AgentsIBA 02/2018 - 02/2004
13	Fetal Proteins (Fetoprotein)IBA 11/2017 - 05/2011
12	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2022 - 01/2008
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 03/2009
12	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 05/2009
12	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2020 - 01/2010
11	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2023 - 07/2008
11	InterferonsIBA 01/2022 - 01/2014
11	CreatinineIBA 01/2020 - 01/2002
10	Thioacetamide (Thioacetamid)IBA 01/2021 - 03/2005
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 08/2008
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2010
9	CytokinesIBA 01/2022 - 03/2009
9	Hepatitis B e AntigensIBA 09/2021 - 03/2010
9	Proteins (Proteins, Gene)FDA Link 12/2017 - 05/2009
8	Serum AlbuminIBA 12/2018 - 02/2010
7	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 10/2004
7	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 11/2012
7	EndotoxinsIBA 01/2018 - 03/2005
6	LipidsIBA 01/2023 - 07/2008
6	Anti-Bacterial Agents (Antibiotics)IBA 02/2020 - 03/2004
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 08/2009
6	Endothelin-1 (Endothelin 1)IBA 01/2018 - 05/2012
6	CannabinoidsIBA 11/2014 - 02/2006
6	Nitric Oxide Synthase (NO Synthase)IBA 01/2012 - 01/2002
5	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2013
5	LeptinIBA 01/2023 - 05/2012
5	entecavir FDA Link 09/2022 - 03/2010
5	Choline (Choline Chloride)IBA 01/2022 - 12/2012
5	Methionine (L-Methionine)FDA Link 01/2022 - 12/2012
5	salicylhydroxamic acid (SHAM)IBA 12/2021 - 04/2010
5	EnzymesIBA 01/2021 - 07/2007
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2016 - 10/2008
5	EndocannabinoidsIBA 08/2015 - 05/2007
5	TerlipressinIBA 01/2014 - 06/2004
5	Messenger RNA (mRNA)IBA 01/2014 - 06/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 07/2008
4	SofosbuvirIBA 01/2024 - 01/2021
4	Ribavirin (Virazole)FDA LinkGeneric 10/2021 - 02/2018
4	Therapeutic UsesIBA 12/2017 - 06/2010
4	Oxygen (Dioxygen)IBA 11/2017 - 04/2013
4	Thalidomide (Thalomid)FDA Link 12/2016 - 03/2009
4	Clopidogrel (Plavix)FDA Link 12/2016 - 11/2012
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2016 - 08/2008

Therapy/Procedure

49	Therapeutics 04/2024 - 03/2004
35	Ligation 01/2020 - 02/2002
16	Radiofrequency Ablation 10/2020 - 01/2008
16	Liver Transplantation 02/2018 - 12/2004
11	Surgical Instruments (Clip) 03/2016 - 05/2006
9	Drug Therapy (Chemotherapy) 09/2022 - 05/2009